Association of hyperuricemia and type 2 diabetes mellitus with cognitive functions assessed using the event-related P300 potential in older individuals with controlled arterial hypertension
- Authors: Krivonogova O.V.1,2, Krivonogova E.V.1,2, Poskotinova L.V.1,2
-
Affiliations:
- Federal Research Center for Comprehensive Study of the Arctic named after Academician N.P. Laverov
- Northern State Medical University
- Issue: Vol 31, No 6 (2024)
- Pages: 484-493
- Section: ORIGINAL STUDY ARTICLES
- URL: https://journal-vniispk.ru/1728-0869/article/view/314523
- DOI: https://doi.org/10.17816/humeco637358
- ID: 314523
Cite item
Full Text
Abstract
BACKGROUND: The number of individuals with dementia and cognitive impairment is steadily increasing worldwide. Identifying and controlling risk factors for cognitive decline is crucial for preserving cognitive function.
AIM: To assess the association of hyperuricemia and type 2 diabetes mellitus (T2DM) with cognitive functions, evaluated using parameters of the auditory event-related P300 potential in elderly individuals with controlled arterial hypertension (AH).
MATERIALS AND METHODS: A cohort of individuals aged 60–74 years was examined. Four groups were formed: Group I (control), without cardiovascular diseases or diabetes, and with normal uric acid levels (n=42); Group II, with controlled AH (n=87); Group III, with controlled AH and T2DM (n=34); and Group IV, with controlled AH and hyperuricemia (n=17). The parameters of the auditory event-related P300 potential were assessed using an electroencephalograph (Neuron-Spectrum-4/VPM, Russia).
RESULTS: No statistically significant differences in P300 latency and amplitude were found in older individuals with controlled AH compared to the control group. In the group with T2DM and controlled AH, an increase in P300 latency and a decrease in amplitude were observed compared to the control group. In the group with hyperuricemia and controlled AH, a lower P300 amplitude was detected compared to the control group.
CONCLUSION: Older individuals with hyperuricemia and controlled AH exhibited a lower P300 amplitude, indicating reduced attentional resources. Those with controlled AH and T2DM showed increased P300 latency and decreased amplitude, reflecting slower information processing, prolonged decision-making time, and diminished attentional resources.
Full Text
##article.viewOnOriginalSite##About the authors
Olga V. Krivonogova
Federal Research Center for Comprehensive Study of the Arctic named after Academician N.P. Laverov; Northern State Medical University
Email: ja.olga1@gmail.com
ORCID iD: 0000-0002-7267-8836
SPIN-code: 1086-3008
Cand. Sci. (Biology)
Russian Federation, 20 Nikolsky ave, Arkhangelsk, 163020; ArkhangelskElena V. Krivonogova
Federal Research Center for Comprehensive Study of the Arctic named after Academician N.P. Laverov; Northern State Medical University
Author for correspondence.
Email: elena200280@mail.ru
ORCID iD: 0000-0002-2323-5246
SPIN-code: 9022-9696
Cand. Sci. (Biology)
Russian Federation, 20 Nikolsky ave, Arkhangelsk, 163020; ArkhangelskLilia V. Poskotinova
Federal Research Center for Comprehensive Study of the Arctic named after Academician N.P. Laverov; Northern State Medical University
Email: liliya200572@mail.ru
ORCID iD: 0000-0002-7537-0837
SPIN-code: 3148-6180
Dr. Sci. (Biology), MD, Cand. Sci. (Medicine), Associate Professor
Russian Federation, 20 Nikolsky ave, Arkhangelsk, 163020; ArkhangelskReferences
- Zueva IB, Krivonosov DS, Buch AV. Assessment of cognitive functions using cognitive evoked potential in patients with arterial hypertension. International Heart and Vascular Disease Journal. 2017;5(13):9–12. EDN: YQEDLT
- Drapkina OM, Mazurov VI, Martynov AI, et al. "Focus on hyperuricemia". The resolution of the Expert Council. Cardiovascular Therapy and Prevention. 2023;22(4):77–84. doi: 10.15829/1728-8800-2023-3564 EDN: KRCKAU
- Tana C, Ticinesi A, Prati B, et al. Uric Acid and cognitive function in older individuals. Nutrients. 2018;10(8):975. doi: 10.3390/nu10080975
- Mijailovic NR, Vesic K, Borovcanin MM. The influence of serum uric acid on the brain and cognitive dysfunction. Frontiers in Psychiatry. 2022;13:828476. doi: 10.3389/fpsyt.2022.828476
- Shalnova SA, Deev AD, Artamonov GV, et al. Hyperuricemia and its correlates in the Russian population (results of ESSE-RF epidemiological study). Rational Pharmacotherapy in Cardiology. 2014;10(2):153–159. doi: 10.20996/1819-6446-2014-10-2-153-159 EDN: SCOUHN
- Putilina MV. Comorbidity in elderly patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2016;116(5):106–111. doi: 10.17116/jnevro201611651106-111 EDN: WAPALL
- Ostroumova OD, Parfenov VA, Ostroumova TM, et al. Expert consensus. Effect of antihypertensive therapy on cognitive functions. Systemic Hypertension. 2021;18(1):5–12. doi: 10.26442/2075082X.2021.1.200575 EDN: EXNFNY
- Choi HK, Soriano LC, Zhang Y, Rodríguez, L.A. Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study. BMJ. 2012;344:d8190. doi: 10.1136/bmj.d8190
- Zaharov VV, Vahnina NV. Cognitive disorders in arterial hypertension. Nervous Diseases. 2013;(3):16–21. (In Russ.) EDN: RHTULZ
- Sánchez-Nieto JM, Rivera-Sánchez UD, Mendoza-Núñez VM. Relationship between arterial hypertension with cognitive performance in elderly. Systematic review and meta-analysis. Brain Sci. 2021;11(11):1445. doi: 10.3390/brainsci11111445
- de Menezes ST, Giatti L, Brant LCC, et al. Hypertension, prehypertension, and hypertension control: association with decline in cognitive performance in the ELSA-Brasil Cohort. Hypertension. 2021;77(2):672–681. doi: 10.1161/hypertensionaha.120.16080
- Dzhos YuS, Kalinina LP. Cognitive event-related potentials in neurophysiology research (review). Journal of Medical and Biological Research. 2018;6(3):223–235. doi: 10.17238/issn2542-1298.2018.6.3.223 EDN: XZOGBV
- Saedi E, Gheini MR, Faiz F, Arami MA. Diabetes mellitus and cognitive impairments. World Journal of Diabetes. 2016;7(17):412–422. doi: 10.4239/wjd.v7.i17.412
- Kálcza Jánosi K, Lukács A. Independent and interactive effect of type 2 diabetes and hypertension on memory functions in middle aged adults. BMC Endocrine Disorders. 2023;23(1):59. doi: 10.1186/s12902-023-01308-3
- Anandhalakshmi S, Rajkumar R, Arulmurugan K, et al. Study of neurocognitive function in type 2 diabetes mellitus patients using P300 event-related potential. Annals of Neurosciences. 2020;27(3-4):98–103. doi: 10.1177/0972753120966824
- Alvarenga Kde F, Duarte JL, Silva DP, et al. Cognitive P300 potential in subjects with Diabetes Mellitus. Brazilian Journal of Otorhinolaryngology. 2005;71(2):202–207. doi: 10.1016/s1808-8694(15)31311-2
- Cook S, Malyutina S, Kudryavtsev AV, et al. Know Your Heart: rationale, design and conduct of a cross-sectional study of cardiovascular structure, function and risk factors in 4500 men and women aged 35–69 years from two Russian cities, 2015–18. Wellcome Open Research. 2018;3:67. doi: 10.12688/wellcomeopenres.14619.3
- Drapkina OM, Shalnova SA, Imaeva AE, et al. Epidemiology of cardiovascular diseases in regions of Russian Federation. Third survey (ESSE-RF-3). Rationale and study design. Cardiovascular Therapy and Prevention. 2022;21(5):48–57. doi: 10.15829/1728-8800-2022-3246 EDN: EZUGUW
- Drachev SN, Popov VA, Simakova AA, et al. Study profile: oral health assessment among participants of “Epidemiology of cardiovascular diseases in Russian regions. Third study” in the Arkhangelsk region. Ekologiya cheloveka (Human Ecology). 2022;29(7):513–526. doi: 10.17816/humeco109191 EDN: JBRRMF
- Gnezditskiy VV, Korepina OS, Chatskaya AV, Klochkova OI. Memory, cognition and the endogenous evoked potentials of the brain: the estimation of the disturbance of cognitive functions and capacity of working memory without the psychological testing. Progress in Physiological Science. 2017;48(1):3–23. EDN: YKVECX
- Polich J, Herbst KL. P300 as a clinical assay: rationale, evaluation, and findings. Int J Psychophysiol. 2000;38(1):3–19. doi: 10.1016/s0167-8760(00)00127-6
- Ostroumova OD, Surkova EV, Shikh EV, et al. Cognitive impairment in patients with type 2 diabetes mellitus: prevalence, pathogenetic mechanisms, the effect of antidiabetic drugs. Diabetes Mellitus. 2018;21(4):307–318. doi: 10.14341/DM9660 EDN: VJNTYI
- Zhang S, Zhang Y, Wen Z, et al. Cognitive dysfunction in diabetes: abnormal glucose metabolic regulation in the brain. Front Endocrinol (Lausanne). 2023;14:1192602. doi: 10.3389/fendo.2023.1192602
- Tian T, Liu X R, Li TT, et al. Detrimental effects of long-term elevated serum uric acid on cognitive function in rats. Scientific Reports. 2021;11(1):6732. doi: 10.1038/s41598-021-86279-y
Supplementary files
